Trial Profile
A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine/hydrochlorothiazide (Primary) ; Amlodipine; Hydrochlorothiazide; Olmesartan medoxomil/amlodipine; Olmesartan medoxomil/hydrochlorothiazide
- Indications Essential hypertension; Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms TRINITY
- 01 Mar 2012 Results of the open-label extension study published in the Journal of Clinical Hypertension.
- 01 Dec 2011 Results of substudy on ambulatory blood pressure published in the Journal of Clinical Hypertension (Greenwich).
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.